Published in Cancer Weekly, February 19th, 1996
Many gene therapy protocols could benefit from the ability to determine which cells have been successfully transduced. Most of the marker genes used to date, have been larger, and express themselves internally. HSA, being smaller (therefore taking up less space on the vector, and leaving more room for the therapeutic gene) as well as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.